Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Polish Cardiac Society | OTHER |
Not provided
Not provided
Not provided
Not provided
Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE. All institutionalized PERTs in Poland have been invited to join the study. The goal of this registry is to describe current practice and outcomes in patients with acute PE treated by Polish PERTs.
Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The presentation of PE may vary from asymptomatic or mild exertion disturbances (low-risk PE) treated with anticoagulants only to hemodynamic "obstructive" collapse and death (high-risk PE). Patient outcome depends on ability of the right ventricle to sustain the increased afterload caused by the embolic burden. Careful risk stratification is crucial, and the Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE by advancing its recognition, diagnosis, and treatment. All institutionalized PERTs in Poland have been invited to join the study. The data is administrated by the Poznan University of Medical Sciences on the basis of an agreement between the PERT centres.
The goal of this registry is to describe current practice and outcomes in patients with acute PE guided by Polish PERTs. The primary data recorded include details of each patient's clinical status, co-morbidities, the administered treatment modalities, the results of additional studies (ab tests results, ECG, imaging studies), and the outcome.
The data collection will have no impact on the way the patient is diagnosed and treated.The study endpoints comprise respiratory failure, shock, death distal systemic embolization (i.e. stroke) and major or minor bleeding complications classified according to the International Society on Thrombosis and Haemostasis classification.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intermediate-high risk PE | Confirmed PE causing right ventricle dysfunction confirmed by computed tomography pulmonary angiography or transthoracic echocardiography and elevated troponin level | ||
| High-risk PE | Confirmed PE causing hemodynamic instability:
|
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Clinical improvement during hospitalization | Incidence of arterial blood saturation increase >92% | 24 hours after specific PE treatment implementation |
| Ventricular strain reduction | Rate of right ventricular strain reduction (right ventricle/left ventricle ratio assessment) in echocardiography | 24 hours after specific PE treatment implementation |
| Early mortality rate from pulmonary embolism | Number of patients who died from pulmonary embolism (right heart failure) | Two weeks since PE diagnosis |
| Measure | Description | Time Frame |
|---|---|---|
| Total mortality rate from pulmonary embolism | Number of patients who died from pulmonary embolism (right heart failure) | 3 months since PE diagnosis |
| Bleeding events incidence | Incidence of major bleedings assessed using ISTH criteria |
Not provided
Inclusion Criteria:
PE confirmed by computed tomography pulmonary angiography.
PE symptoms duration ≤ 14 days.
High-risk PE with hemodynamic instability (one of):
Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level.
Exclusion Criteria:
1. Refusal to sign the informed consent form.
Not provided
Not provided
Not provided
Consecutive patients hospitalized due to high-risk or intermediate-high risk PE.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Aleksander Araszkiewicz | Contact | 8549146 | +48 | aaraszkiewicz@ump.edu.pl |
| Sylwia Sławek-Szmyt | Contact | 8549293 | +48 | sylwia.slawek@skpp.edu.pl |
| Name | Affiliation | Role |
|---|---|---|
| Aleksander Araszkiewicz, Prof. | Poznan University of Medical Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Poznan University of Medical Sciences | Recruiting | Poznan | GreaterPoland | 61-848 | Poland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40045310 | Derived | Slawek-Szmyt S, Stepniewski J, Kurzyna M, Klaudel J, Kuliczkowski W, Lewandowski M, Grabka M, Roik M, Ordiene R, Jankiewicz S, Kopec G, Darocha S, Mroczek E, Widecka K, Kurzyna P, Lesiak M, Pruszczyk P, Araszkiewicz A. Multicentre, real-world data of next-generation computer-assisted vacuum aspiration thrombectomy in acute pulmonary embolism. Respir Res. 2025 Mar 5;26(1):87. doi: 10.1186/s12931-025-03162-4. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011655 | Pulmonary Embolism |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D004617 | Embolism |
| D016769 | Embolism and Thrombosis |
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 months since PE diagnosis |
| D014652 |
| Vascular Diseases |
| D002318 | Cardiovascular Diseases |